Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity.
![Thumbnail](/bitstream/handle/10576/11456/cancers-11-00363.pdf.jpg?sequence=5&isAllowed=y)
View/ Open
Date
2019-03-01Author
Gupta, IshitaSareyeldin, Rasha M.
Al-Hashimi, Israa
Al-Thawadi, Hamda A.
Al Farsi, Halema
Vranic, Semir
Al Moustafa, Ala-Eddin
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Breast cancer is the most frequent cause of cancer-related deaths among women worldwide. It is classified into four major molecular subtypes. Triple-negative breast cancers (TNBCs), a subgroup of breast cancer, are defined by the absence of estrogen and progesterone receptors and the lack of HER-2 expression; this subgroup accounts for ~15% of all breast cancers and exhibits the most aggressive metastatic behavior. Currently, very limited targeted therapies exist for the treatment of patients with TNBCs. On the other hand, it is important to highlight that knowledge of the molecular biology of breast cancer has recently changed the decision-making process regarding the course of cancer therapies. Thus, a number of new techniques, such as gene profiling and sequencing, proteomics, and microRNA analysis have been used to explore human breast carcinogenesis and metastasis including TNBC, which consequently could lead to new therapies. Nevertheless, based on evidence thus far, genomics profiles (gene and miRNA) can differ from one geographic location to another as well as in different ethnic groups. This review provides a comprehensive and updated information on the genomics profile alterations associated with TNBC pathogenesis associated with different ethnic backgrounds.
Collections
- Biomedical Research Center Research [709 items ]
- Medicine Research [1382 items ]